Co-Authors
This is a "connection" page, showing publications co-authored by John Laffey and Natalie McEvoy.
Connection Strength
0.235
-
A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial. Trials. 2021 Apr 19; 22(1):288.
Score: 0.235